About CellDrop

CellDrop Biosciences Inc. is a spinout from the University of Wyoming, and is founded on the goal of translating cutting edge research from the benchtop to the bedside. Our product pipeline leverages extensive experience using microfluidics and hydrogel microengineering to build better biomaterials, biomaterial delivery systems, and diagnostic devices. We aim to commercialize technology that can help both people and animals live to their fullest potential by fusing biology with clever engineering to heal injuries and optimize natural biological function.

Meet our team

Dr. Benjamin Noren
Dr. Benjamin Noren
CEO
Dr. John Oakey
Dr. John Oakey
CTO
Prof. Peter Scott
Prof. Peter Scott
CFO

Our Partners

CellDrop Biosciences Inc. has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant for $256,000 to conduct research and development work on Hydrogel based Allogeneic Stem Cell Delivery for Efficacy-Enhanced Equine Biotherapeutics.
CellDrop Biosciences Inc., a University of Wyoming spinout, is part of a $354,000 grant to develop sensitive and extremely fast antigen tests.
Interested in joining our team?
If you think you might be a good addition, send your resume to
ben@celldrop.co